Benitec Biopharma Inc. (BNTC) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
BNTC Revenue Growth
Revenue Breakdown (FY 2023)
BNTC's revenue distribution by segment and geography for fiscal year 2023
By Product/Segment
By Geography
BNTC Revenue Analysis (2014–2025)
As of May 8, 2026, Benitec Biopharma Inc. (BNTC) generated trailing twelve-month (TTM) revenue of $556,000. The most recent quarter (Q2 2026) recorded $0 in revenue.
Looking at the longer-term picture, BNTC's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $11.3 million in 2019.
Revenue diversification analysis shows BNTC's business is primarily driven by License (100%). With over half of revenue concentrated in License, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including KRYS (+25.1% YoY), QURE (-10.4% YoY), and DTIL (-11.9% YoY). Compare BNTC vs KRYS →
BNTC Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| BNTCCurrent | $556,000 | - | - | - | |
 KRYS | $389M | +25.1% | - | 41.5% | |
 QURE | $16M | -10.4% | -15.6% | -1166.8% | |
 DTIL | $34M | -11.9% | +7.1% | -152.2% |
BNTC Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $-396,000 | - | $-41,765,000 | - |
| 2024 | $0 | -100.0% | $-343,000 | - | $-22,598,000 | - |
| 2023 | $75K | +2.7% | $-306,000 | -408.0% | $-19,081,000 | -25441.3% |
| 2022 | $73K | +23.7% | $64K | 87.7% | $-17,854,000 | -24457.5% |
| 2021 | $59K | -39.2% | $-64,000 | -108.5% | $-13,596,000 | -23044.1% |
| 2020 | $97K | -99.1% | $282K | 290.7% | $-8,281,000 | -8537.1% |
| 2019 | $11.3M | +2384.8% | $10.9M | 96.2% | $2.0M | 17.7% |
| 2018 | $455K | +1.1% | $124K | 27.3% | $-8,552,119 | -1877.7% |
| 2017 | $450K | +30.0% | $241K | 53.6% | $-15,924,000 | -3536.2% |
| 2016 | $347K | -58.2% | $243K | 70.0% | $-24,963,000 | -7204.2% |
See BNTC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BNTC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BNTC vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonBNTC — Frequently Asked Questions
Quick answers to the most common questions about buying BNTC stock.
Is BNTC's revenue growth accelerating or slowing?
BNTC TTM revenue: $556000.00. YoY growth: N/A. 5-year CAGR: N/A.
What is BNTC's long-term revenue growth rate?
Benitec Biopharma Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is BNTC's revenue distributed by segment?
BNTC reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.